title: Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.
abstract: The main aim of this study was to evaluate the clinical relevance of Gelatinases in colorectal cancer (CRC). Ninety-five CRCs and their paired normal tissues were investigated to detect total levels of MMP-9, MMP-2, and the tissue inhibitors TIMP-1 and TIMP-2. Also, pro-MMP and MMP activity, and potential associations with clinical parameters were estimated. MMP-9, MMP-2 and TIMP-1 levels were greater in CRCs than in normal tissues, differences being significant for MMP-9 and TIMP-1. However, TIMP-2 showed significantly lower levels in tumour samples. Moreover, significant differences in the state of activation between gelatinases were found. TIMP-1 low levels were significantly associated with poor clinical outcome of patients. According to these data, different roles have to be attributed to MMP-2 and MMP-9 in CRC progression. Moreover, TIMP-1 level evaluation emerges as the main prognostic factor in relation to Gelatinases A and B activity in CRC.
authors.affiliation: Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense, 28040-Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Morán
authors.forename: P
authors.initials: P
authors.lastname: Iniesta
authors.forename: C
authors.initials: C
authors.lastname: García-Aranda
authors.forename: C
authors.initials: C
authors.lastname: De Juan
authors.forename: A
authors.initials: A
authors.lastname: Díaz-López
authors.forename: A
authors.initials: A
authors.lastname: Sánchez-Pernaute
authors.forename: A J
authors.initials: AJ
authors.lastname: Torres
authors.forename: E
authors.initials: E
authors.lastname: Díaz-Rubio
authors.forename: J L
authors.initials: JL
authors.lastname: Balibrea
authors.forename: M
authors.initials: M
authors.lastname: Benito
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000201:enzymology / Q000378:metabolism; D000368:Aged; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000378:metabolism; D015536:Down-Regulation; D005260:Female; D006801:Humans; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000032:analysis / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000032:analysis / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000032:analysis / Q000378:metabolism*; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000032:analysis / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D019715:Tissue Inhibitor of Metalloproteinase-1; D019716:Tissue Inhibitor of Metalloproteinase-2; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9